MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/jnnp-2020-323999

Медицинская библиотека · Journal of neurology, neurosurgery, and psychiatry · 2020

Medical treatment of SUNCT and SUNA: a prospective open-label study including single-arm meta-analysis.

Lambru Giorgio, Stubberud Anker, Rantell Khadija, Lagrata Susie, Tronvik Erling, Matharu Manjit Singh

Сравнительное исследованиеСтатьяМетаанализПеревод в очереди

Аннотация

INTRODUCTION

The management of short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) and short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA) remains challenging in view of the paucity of data and evidence-based treatment recommendations are missing.

METHODS

In this single-centre, non-randomised, prospective open-label study, we evaluated and compared the efficacy of oral and parenteral treatments for SUNCT and SUNA in a real-world setting. Additionally, single-arm meta-analyses of the available reports of SUNCT and SUNA treatments were conducted.

RESULTS

The study cohort comprised 161 patients. Most patients responded to lamotrigine (56%), followed by oxcarbazepine (46%), duloxetine (30%), carbamazepine (26%), topiramate (25%), pregabalin and gabapentin (10%). Mexiletine and lacosamide were effective in a meaningful proportion of patients but poorly tolerated. Intravenous lidocaine given for 7-10 days led to improvement in 90% of patients, whereas only 27% of patients responded to a greater occipital nerve block. No statistically significant differences in responders were observed between SUNCT and SUNA. In the meta-analysis of the pooled data, topiramate was found to be significantly more effective in SUNCT than SUNA patients. However, a higher proportion of SUNA than SUNCT was considered refractory to medications at the time of the topiramate trial, possibly explaining this isolated difference.

CONCLUSIONS

We propose a treatment algorithm for SUNCT and SUNA for clinical practice. The response to sodium channel blockers indicates a therapeutic overlap with trigeminal neuralgia, suggesting that sodium channels dysfunction may be a key pathophysiological hallmark in these disorders. Furthermore, the therapeutic similarities between SUNCT and SUNA further support the hypothesis that these conditions are variants of the same disorder.

Для цитирования: Lambru Giorgio, Stubberud Anker, Rantell Khadija, Lagrata Susie, Tronvik Erling, Matharu Manjit Singh. Medical treatment of SUNCT and SUNA: a prospective open-label study including single-arm meta-analysis.. Journal of neurology, neurosurgery, and psychiatry. 2020. DOI: 10.1136/jnnp-2020-323999.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.